Netherlands· NL-8996db7ef019

Nimvastid 4,5 mg orodispergeerbare tablet, orodispergeerbare tablet

A rivastigmine product containing rivastigminewaterstoftartraat, registered in Netherlands by Krka d.d., Novo mesto. The same ATC class is registered in 18 of our 19 countries.

ATC N06DA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rivastigminewaterstoftartraatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rivastigmine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06DA03 (rivastigmine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search rivastigmine products by name

Rivastigmine · ATC N06DA03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rivastigmine costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $0.042 in Czechia to $2.19 in Italy — a ×52 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rivastigmine · price per daily dose (9 mg)

USD · FX 28 Sept 2026

IT Italy$2.19
CH Switzerland$1.33
CZ Czechia$0.042

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: RIVASTIGMINEWATERSTOFTARTRAAT
Manufacturer: Krka d.d., Novo mesto
Country: Netherlands (NL)
ATC code: N06DA03
ATC class: Rivastigmine
Defined daily dose: 9 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/09/525

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

235 interactions on record for rivastigmine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rivastigmine against other medicines How interaction checks work

Rivastigmine · interactions on record

235 records

8 severe
166 moderate
59 info

Most severe, free to view

OzanimodL04AA38severe
SiponimodL04AA42severe
OzanimodL04AE02severe
SiponimodL04AE03severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rivastigmine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rivastigmine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Austria · Nimgista, Rivagelan
Belgium · Rivastigmin Sandoz, Rivastigmine Viatris
Bulgaria · Ридаксин
Germany · Demelora, Rivastigmin
Denmark · Rigmin, Rivastigmin Orion
Spain · Alzerta, Alzerta Dos Por Semana
Finland · Rivastigmin Orion, Rivastigmine Sandoz
France · Rivastigmine Arrow, Rivastigmine Biogaran
United Kingdom (Northern Ireland) · Almuriva, Alzest
Greece · Alapril, Balaxon
Iceland · Exelon, Nimvastid
Italy · Demelora, Rivastigmina Aurobindo
Liechtenstein · Exelon, Rivastigmine 1 A Pharma
Malta · Rivastigmine Aurobindo
Norway · Exelon, Nimvastid
Poland · Atmina, Evertas
Portugal · Nervopan, Rivastigmina Alter
Romania · Evertas, Ridaxin
Sweden · Rigmin, Rivastigmin Orion
Slovenia · Rivastigmin Teva, Rivastigmin Teva B.V.
Slovakia · Ristidic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dbd405ec-ab7e-40fe-91d3-3c1f27e80e85
GET /v1/drugs/dbd405ec-ab7e-40fe-91d3-3c1f27e80e85?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Orodispergeerbare tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nimvastid-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Rivastigmine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp102908",
  "excipients": [
    "ARABISCHE GOM (E 414)",
    "CALCIUMSILICAAT (E 552)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "KRUISMUNTSMAAKSTOF",
    "LEVOMENTHOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "MUNT OLIE",
    "PEPERMUNTOLIE",
    "PEPERMUNTSMAAKSTOF",
    "SORBITOL (E 420)"
  ],
  "substances": [
    "RIVASTIGMINEWATERSTOFTARTRAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2009/05/11",
  "procedure_number": "EMEA/H/C/001029",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/09/525",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about rivastigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console